Value of positron emission tomography parameters for the prognosis of small-cell lung carcinoma

Ö. Özdemir (Izmir, Turkey), Ö. Batum (Izmir, Turkey), S. Ermin (Izmir, Turkey), N. Aksel (Izmir, Turkey), B. Kömürcüoglu (Izmir, Turkey), A. Mertoglu (Izmir, Turkey), S. Deniz (Izmir, Turkey), G. Balci (Izmir, Turkey), H. Koparal (Izmir, Turkey), E. Özbilek (Izmir, Turkey), U. Yilmaz (Izmir, Turkey)

Source: International Congress 2019 – Biology and prognosis of lung cancer
Session: Biology and prognosis of lung cancer
Session type: Thematic Poster
Number: 3047
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ö. Özdemir (Izmir, Turkey), Ö. Batum (Izmir, Turkey), S. Ermin (Izmir, Turkey), N. Aksel (Izmir, Turkey), B. Kömürcüoglu (Izmir, Turkey), A. Mertoglu (Izmir, Turkey), S. Deniz (Izmir, Turkey), G. Balci (Izmir, Turkey), H. Koparal (Izmir, Turkey), E. Özbilek (Izmir, Turkey), U. Yilmaz (Izmir, Turkey). Value of positron emission tomography parameters for the prognosis of small-cell lung carcinoma. 3047

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

The role of positron emission tomography scan in the preoperative staging of nonsmall cell lung cancer
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008

Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET)
Source: Eur Respir J 2004; 24: Suppl. 48, 457s
Year: 2004

The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: Eur Respir J 2001; 17: 802-820
Year: 2001



Fluorodeoxyglucose positron emission tomography (FDG-PET) for detection and staging of bronchioloalveolar carcinoma
Source: Eur Respir J 2001; 18: Suppl. 33, 18s
Year: 2001

Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
Source: Eur Respir J 2009; 33: 201-212
Year: 2009



Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer
Source: Eur Respir J 2007; 29: 995-1002
Year: 2007



The importance of positron emission tomography/computed tomography (PET-CT) to identify distant metastasis in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 227s
Year: 2001

Assessing nodules detected in lung cancer screening: the value of positron emission tomography
Source: Eur Respir J 2015; 45: 314-316
Year: 2015


Clinicopathologic comparison of computed tomography and positron emission tomography scanning for mediastinal staging in NSCLC
Source: Annual Congress 2010 - Actual challenges in thoracic surgery
Year: 2010



The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245
Year: 2004

Imaging in lung cancer: positron emission tomography scan
Source: Eur Respir J 2002; 19: 49S-60S
Year: 2002



The relation of fluorine-18 fluorodeoxyglucose positron emission tomography imaging to chemosensitivity for platinum doublet chemotherapy in patients with advanced stage non small cell lung cancer
Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer
Year: 2009



Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer
Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer
Year: 2008


Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002

Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET)
Source: Eur Respir J 2001; 18: Suppl. 33, 396s
Year: 2001

Accuracy of positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) in diagnosis of recurrence of lung cancer after curative first-line therapy: visual and semiquantitative PET analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002

Computed tomography in staging for lung cancer
Source: Eur Respir J 2002; 19: 40S-48S
Year: 2002



Positron emission tomography in the diagnostic work-up of screening-detected lung nodules
Source: Eur Respir J 2015; 45: 501-510
Year: 2015